XRAY
DENTSPLY SIRONA Inc.
$10.21
Distressed or Transitioning
75%
Current FCF × Depressed Multiple
Strong
·
Conviction
Overvalued
Trading 147.5% above fair value
Bear
$0.00
-100.0%
FCF continues to decline, 4x multiple
Fair
$4.12
-59.6%
Current FCF stabilizes, 6x multiple
Bull
$0.00
-100.0%
Credible recovery, multiple re-rates to 8x
Key Value Driver
Whether the core business model is intact or structurally impaired
Implied Market Multiple
40.3x
Summary
Our base-case estimate uses Current FCF × Depressed Multiple. We then blend that result with the average analyst price target of $13.75 from 31 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $4.12 per share.
Warnings
Don't assume past cash flow levels will return — the company's troubles may have permanently reduced its ability to generate profits.
A stock can look cheap on paper and still lose half its value if the underlying business is permanently damaged.
The wide range between our best and worst cases is intentional — pretending to know a precise value for a troubled company would be misleading.
Debt per share ($10.69) is more than half the stock price. With this much debt on a struggling business, the paths to recovery for shareholders are narrow.
Wall Street's average price target is $13.75 (from 31 analysts). Our estimate is 100% below the consensus -- consider that gap carefully.
Key Risks
- Bullish DCF projections are fundamentally unknowable for distressed companies
- M&A speculation can floor the stock above intrinsic value temporarily
- Management credibility is a key input — new CEO expands the bull case